Consistent with this, several studies documented an association between reduced activity levels of ADAMTS-13 and mortality [8,9].We previously found that ADAMTS-13, at hospital admission, predicts mortality in COVID-19 patients [10]. This evidence concerns the gene ADAMTS13 and COVID-19.